SCHEMBL3898110

SCHEMBL3898110

COC(=O)Cc1ccccc1N1CCCC(C(N)C(=O)c2sc(-c3ccc(Cl)cc3)cc2C)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 7/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
CASP3 P42574 1/20 0.35
RAB9A P51151 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
CCR1 P32246 1/20 0.34
DPP4 P27487 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
SCN2A Q99250 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
CHEK1 O14757 1/20 0.33
ACHE P22303 1/20 0.33
KCNH2 Q12809 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3892370 0.86 PPARA (0.46) PPARAMAPTNPC1RAB9APPARG
SCHEMBL3898111 0.82 PPARA (0.50) PPARAKDM4EMAPTNPC1CCR1
SCHEMBL3905840 0.79 PPARA (0.45) PPARAMAPTNPC1RAB9APPARG
SCHEMBL3896903 0.77 NPC1 (0.44) PPARAMAPTNPC1PPARGPPARD
SCHEMBL3890824 0.75 PPARA (0.44) PPARAPPARGPPARD
SCHEMBL3892209 0.75 PPARA (0.55) PPARAPPARGPPARD
SCHEMBL2069329 0.72 PPARA (0.48) PPARAKDM4EMAPTNPC1RAB9A
SCHEMBL3889698 0.72 PPARA (0.64) PPARAPPARGPPARD
SCHEMBL3902306 0.71 PPARA (0.42) PPARAKDM4EMAPTNPC1RAB9A
SCHEMBL2070653 0.70 SLC6A3 (0.41) KDM4EMAPTNPC1RAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090036489-A1 Novel Cyclic Aminophenylalkanoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036489-A1 Novel Cyclic Aminophenylalkanoic Acid Derivative PPARA, PPARD, PPARG PPARA 1/4885KDM4E 2529/4885MAPT 4346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.